Annexon, Inc. Competitors
Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
---|---|---|---|---|---|
![]() ABOS
Acumen Pharmaceuticals, Inc. |
$1.85 | $157.41 M | -2.5 | 51 | $0 |
![]() AMLX
Amylyx Pharmaceuticals, Inc. |
$3.92 | $120.37 M | -1.65 | 384 | $87.37 M |
![]() AVRO
AVROBIO, Inc. |
$1.40 | $68.24 M | 2.2 | 13 | $0 |
![]() BPMC
Blueprint Medicines Corporation |
$89.54 | $6.47 B | -21.48 | 649 | $508.82 M |
![]() CGEM
Cullinan Oncology, Inc. |
$11.78 | $1.29 B | -7.16 | 111 | $0 |
![]() CNSP
CNS Pharmaceuticals, Inc. |
$0.12 | $1.20 M | -0.01 | 3 | $0 |
![]() DAWN
Day One Biopharmaceuticals, Inc. |
$12.20 | $1.12 B | -5.11 | 181 | $131.16 M |
![]() FRLN
Freeline Therapeutics Holdings plc |
$6.49 | $28.28 M | -0.57 | 152 | $0 |
![]() GPCR
Structure Therapeutics Inc. |
$27.50 | $2.47 B | -23.59 | 163 | $0 |
![]() HEPA
Hepion Pharmaceuticals, Inc. |
$0.65 | $6.02 M | -0.12 | 22 | $0 |
![]() ICVX
Icosavax, Inc. |
$15.31 | $769.04 M | -6.96 | 60 | $582,000 |
![]() IMMX
Immix Biopharma, Inc. |
$2.30 | $53.62 M | -2.18 | 14 | $0 |
![]() INAB
IN8bio, Inc. |
$0.35 | $59.13 M | -1.49 | 18 | $0 |
![]() INZY
Inozyme Pharma, Inc. |
$2.89 | $286.39 M | -3.43 | 67 | $0 |
![]() ISEE
IVERIC bio, Inc. |
$39.95 | $5.51 B | -22.44 | 163 | $0 |
![]() KRTX
Karuna Therapeutics, Inc. |
$329.83 | $12.60 B | -28.09 | 339 | $654,000 |
![]() RCUS
Arcus Biosciences, Inc. |
$14.87 | $1.41 B | -4.98 | 627 | $258.00 M |
![]() RLAY
Relay Therapeutics, Inc. |
$4.57 | $1.05 B | -3 | 261 | $10.01 M |
![]() VECT
VectivBio Holding AG |
$16.87 | $1.06 B | -8.03 | 0 | $27.34 M |
![]() WVE
Wave Life Sciences Ltd. |
$13.03 | $711.49 M | -11.39 | 287 | $108.30 M |
![]() XFOR
X4 Pharmaceuticals, Inc. |
$0.74 | $169.62 M | -1.51 | 143 | $0 |
![]() ZURA
Zura Bio Limited |
$2.50 | $255.37 M | 6.17 | 14 | $0 |